1 study found for:    17242397 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Condition: Diffuse Large B Cell Lymphoma
Intervention: Drug: MK2206

Indicates status has not been verified in more than two years